1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Biosimilars Manufacturing: Key Considerations and Expected Outsourcing Practices

In this report, biopharmaceutical manufacturer decision-makers share their perspectives on:
- Expected outsourcing of commercial biosimilar manufacturing
- Comfort level with outsourcing to individual CMOs
- Market trends and biosimilar manufacturing method preferences

Methodologies:
ISR conducted 68 online quantitative surveys with respondents from biopharmaceutical companies who:
- Have significant influence over outsourced commercial manufacturing activities
- Have been involved in outsourcing commercial manufacturing activities within the past 18 months

How you can use this report:
Manufacturers
- Stay on top of industry trends by learning what biopharmaceutical companies currently manufacturing large molecules think the future holds for biosimilar manufacturing
- Learn what methods of biosimilar manufacturing peers are gravitating towards
- Understand where, geographically, biopharmaceutical companies are looking to manufacturer biosimilars
CMOs
- Start to understand the market potential for outsourced biosimilar manufacturing
- Learn what biopharmaceutical companies would value from a CMO and leverage these drivers in your sales and marketing efforts
- Get an early indication of market leaders by knowing which manufacturers and CMOs respondents would be most comfortable using for biosimilar production

Table Of Contents

Biosimilars Manufacturing: Key Considerations and Expected Outsourcing Practices
Table of Contents

Copyright and Usage Guidelines ..3
Introduction .4
Methodology ...5
Summary Respondent Demographics ..6
Years of Industry Experience .6
Geography .6
Company Size .6
Study Data 7
Biosimilar familiarity ..8
Large molecule products offering ..9
Large vs. small molecule outsourcing ..10
Large molecule manufacturing: in-house vs. outsourcing ...11
Stance on selling biosimilars 12
Stance on manufacturing biosimilars ...13
Biosimilar manufacturing methods ..14
Outsourced biosimilars manufacturing activities .15
Primary biosimilar outsourcing drivers 16
Biosimilar manufacturing, by geography .17
Biosimilar outsourcing comfort, by company ..18
Most difficult aspect of biosimilar manufacturing, unprompted .19
Respondent's likelihood to use biosimilars ..20
Respondent Demographics 21
Company type ..22
Decision making responsibility .23
Primary area of decision making responsibility ...24
Outsourcing influence ..25
Commercial manufacturing responsibilities .26
Job title .27
Involvement in manufacturing process 28
Headquarters location ..29
Office location ..30
Commercial manufacturing activity involvement 31
Years of industry experience 32
About Industry Standard Research 33

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Remicade Biosimilar Market: By Type (Recombinant Non-Glycosylated Protein, Others), By Technology (MAb, rDNA, Others), By Service (Contract Research, CRAMS,Others), By Application (Blood Disorders, Oncology Diseases, Others), By Region-Forecast (2016-2021

Remicade Biosimilar Market: By Type (Recombinant Non-Glycosylated Protein, Others), By Technology (MAb, rDNA, Others), By Service (Contract Research, CRAMS,Others), By Application (Blood Disorders, Oncology Diseases, Others), By Region-Forecast (2016-2021

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Globally, development of efficient and advance technology, higher expiration patent, rise in the awareness among people regarding remicade biosimilar, increasing government initiative across the globe, ...

Biosimilar - Global Market Outlook (2016-2022)

Biosimilar - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • September 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Biosimilars market is estimated to be $3.5 billion in 2015 with a CAGR of 23.8% is poised to reach $15.6 billion by 2022. High end adoption of off patented drugs ...

Insulin Biosimilars - Global Market Outlook (2016-2022)

Insulin Biosimilars - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • October 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Insulin Biosimilars market is accounted for $xx million in 2015 and is expected to reach $xx million by 2022 growing at a CAGR of xx% from 2015 to 2022. Growing ...


Download Unlimited Documents from Trusted Public Sources

Biosimilar Industry in Europe

  • November 2016
    42 pages
  • Biosimilar  

  • Europe  

View report >

Pathology Statistics in Canada

  • October 2016
    2 pages
  • Biosimilar  

  • Canada  

    North America  

View report >

Global Breast Cancer Statistics

  • October 2016
    2 pages
  • Breast Cancer  

    Biosimilar  

  • Europe  

    World  

    Hungary  

View report >

Bioprocessing Industry

3 months ago

Biosimilar Statistics

3 months ago

Biosimilar Statistics

3 months ago

Related Market Segments :

Biosimilar
Manufacturing

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.